The VO2 Increase With Testosterone Addition - Heart Failure (VITA-HF) Trial
A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It plans to enroll 318 participants.
Also called NCT01469988
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 318 participants
- Sponsor
- Registry
-
NCT01469988
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Terminated
Technical summary
Registry record NCT01469988. Randomized; double masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2014-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The VO2 Increase With Testosterone Addition - Heart Failure (VITA-HF) Trial
- Acronym
- VITA-HF
- Condition
- Heart Failure
- Intervention (Drug)
- Testosterone
- Lead sponsor
- University of Alberta
Record details
- Record id
cardio:ct-nct01469988- Content hash
d2f9db37db907be94e02bc5b1c6c79c155b4d4c5ad9cea5173da951cb9e836c1